Richard Penson, MD on Olaparib Versus Nonplatinum Chemotherapy (SOLO3) @MassGeneralNews

Richard Penson, MD on Olaparib Versus Nonplatinum Chemotherapy (SOLO3) @MassGeneralNews

User Photo
Cancer-News

4 months
18 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Richard Penson, MD of Massachusetts General Hospital @MassGeneralNews discusses a randomized phase III of olaparib versus nonplatinum chemotherapy in patients with platinum-sensitive relapsed ovarian cancer and a germline BRCA1/2 mutation (SOLO3).

Read here: https://ascopubs.org/doi/full/10.1200/JCO.19.02745

Up Next Autoplay